Penehyclidine is a synthetic anticholinergic agent primarily used in medical settings for its ability to reduce secretions and as an adjunct in anesthesia. It functions by blocking the action of acetylcholine at muscarinic receptors, leading to decreased salivation, bronchial secretions, and gastrointestinal motility. This compound is characterized by its relatively low solubility in water, which influences its pharmacokinetics and administration routes. Penehyclidine is often utilized in surgical procedures to facilitate intubation and improve surgical conditions by minimizing secretions. Its side effects may include dry mouth, blurred vision, and increased heart rate, typical of anticholinergic medications. The compound's efficacy and safety profile make it a valuable tool in perioperative care, although its use must be carefully monitored to avoid potential adverse effects, especially in patients with pre-existing conditions that may be exacerbated by anticholinergic activity. As with any medication, it is essential to consider individual patient factors when administering penehyclidine.

Penehyclidine

87827-02-9: Penehyclidine is a synthetic anticholinergic agent primarily used in medical settings for its ability to reduce secretions and as an adjunct in anesthesia. It functions by blocking the action of acetylcholine at muscarinic receptors, leading to decreased salivation, bronchial secretions, and gastrointestinal motility. This compound is characterized by its relatively low solubility in water, which influences its pharmacokinetics and administration routes. Penehyclidine is often utilized in surgical procedures to facilitate intubation and improve surgical conditions by minimizing secretions. Its side effects may include dry mouth, blurred vision, and increased heart rate, typical of anticholinergic medications. The compound's efficacy and safety profile make it a valuable tool in perioperative care, although its use must be carefully monitored to avoid potential adverse effects, especially in patients with pre-existing conditions that may be exacerbated by anticholinergic activity. As with any medication, it is essential to consider individual patient factors when administering penehyclidine.

CAS 87827-02-9

Penehyclidine

M 8218

Ref: TM-T33111